Commerce Dashboard

Thyrocare Technologies Limited

Go Back

Thyrocare Technologies Limited

  • Over 1,200 employees
  • 2,000 cities/towns
  • Recorded total income of Rs. 486.55 crore (US$ 66.34 million) for FY21.
  • India's first fully automated diagnostic laboratory

Thyrocare Technologies Limited is an India-based healthcare service provider. The company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests and regional processing laboratory in metro cities of India and other parts of Asia. The company offers technologies like Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ion Selective Electrode (ISE), Fluorescence Flow Cytometry, Nephelometry, Photometry, Liquid Chromatography Mass Spectrometry (LC-MS), Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Cytogenetics. The company offers cancer diagnosis and water testing through its brands, Nueclear and Whaters, respectively. The company tests cover varied age groups from offerings for prenatal screening to screening for hormonal imbalance, nutritional deficiencies and tracking lifestyle disorders.

Company Website:

Thyrocare Technologies Limited: Think Thyroid Think Thyrocare

2018 Patna Regional Processing Laboratory (RRL) was launched.
2017 Awarded The VCCircle healthcare company of the year.
2016 Entered the Public listed sphere of healthcare - IPO
2015 The company opened Regional Processing Laboratories (RPLs) in Delhi, Coimbatore, Hyderabad and Kolkata to expand its coverage and volume of tests and samples processed daily.
2014 The company had installed, India’s first and the world’s longest track automation system for seamless sample movements from Siemens Limited.
2010 The company launched wellness packages under the brand name "Aarogyam".
2007 The company receives accreditation from the College of American Pathologists (CAP).
2005 The company received National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation.
2000 The company was incorporated in the name and style of "Thyrocare Technologies Limited’ and received a certificate for commencement of operations.


The Healthcare industry size is estimated to reach US$ 193.83 billion by 2020 and US$ 372 billion by 2022.